ANI Pharmaceuticals trades at 10x forward earnings with a $93 target, but execution in Cortrophin and ophthalmology recovery may decide if the discount closes.

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ANI Pharmaceuticals (ANIP) is a stock that can certainly grab ...

ANI Pharmaceuticals ANIP and Amneal Pharmaceuticals AMRX are both generic drugmakers, but their overall business models differ. ANIP’s operations are split between rare disease therapies and generics, ...

The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year decline in earnings on higher revenues when it ...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc ...

ANI Pharmaceuticals’ ANIP rare disease franchise spearheaded its growth in 2025. This robust growth was fueled by the strong performance of its ACTH-based injection Cortrophin Gel. Cortrophin Gel ...

The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will ...

Investors in ANI Pharmaceuticals Inc (Symbol: ANIP) saw new options become available today, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...